These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. Wang R; Leong RW World J Gastroenterol; 2014 Jul; 20(27):8783-9. PubMed ID: 25083052 [TBL] [Abstract][Full Text] [Related]
4. The epidemiology of inflammatory bowel disease. Burisch J; Munkholm P Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629 [TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Pardi DS; Loftus EV; Kremers WK; Keach J; Lindor KD Gastroenterology; 2003 Apr; 124(4):889-93. PubMed ID: 12671884 [TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colorectal cancer in ulcerative colitis. Croog VJ; Ullman TA; Itzkowitz SH Int J Colorectal Dis; 2003 Sep; 18(5):392-400. PubMed ID: 12904996 [TBL] [Abstract][Full Text] [Related]
9. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease. Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893 [TBL] [Abstract][Full Text] [Related]
10. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187 [TBL] [Abstract][Full Text] [Related]
11. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study. Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788 [No Abstract] [Full Text] [Related]
12. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years. Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008 [TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence. Bezzio C; Festa S; Saibeni S; Papi C Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):339-347. PubMed ID: 28165825 [TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of colorectal cancer. Das D; Arber N; Jankowski JA Digestion; 2007; 76(1):51-67. PubMed ID: 17947819 [TBL] [Abstract][Full Text] [Related]
16. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah. Jewel Samadder N; Valentine JF; Guthery S; Singh H; Bernstein CN; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Bronner M; Ulrich CM; Burt RW; Curtin K; Smith KR Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782 [TBL] [Abstract][Full Text] [Related]
17. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. Wolf JM; Rybicki LA; Lashner BA Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486 [TBL] [Abstract][Full Text] [Related]
18. Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Samadder NJ; Valentine JF; Guthery S; Singh H; Bernstein CN; Leighton JA; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Burt RW; Curtin K; Smith KR Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1807-1813.e1. PubMed ID: 30267862 [TBL] [Abstract][Full Text] [Related]
19. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613 [TBL] [Abstract][Full Text] [Related]
20. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea. Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]